Renal cancer: cytogenetic and molecular genetic aspects.
To date, much progress has been made in the fields of cytogenetics and molecular genetics of renal tumors. The previous and recent findings have delineated the characteristics of the various tumors, particularly the cytogenetic and molecular differences that exist between papillary and nonpapillary clear cell renal cell carcinomas (RCCs). At the same time, new cytogenetic subtypes have emerged [e.g., t(X;1)] in subtypes of RCC, while in others (e.g., Wilms tumors) several new cytogenetic abnormalities and consequent molecular involvement have been found. In addition to Wilms tumor, papillary RCC, and clear-cell RCC, cytogenetic and fluorescence in situ hybridization analyses have been performed on several other tumors of the kidney, including chromophobic carcinoma, metanephric adenoma, collecting duct carcinoma, transitional cell carcinoma, congenital mesoblastic nephroma, and malignant rhabdoid tumors of the kidney. This review is therefore intended to present a concise update on the cytogenetic and molecular data on renal tumors, focusing mainly on the clinical usefulness of the findings reported in the literature.
Meloni-Ehrig
Aurelia M
AM
University of Utah, School of Medicine, Department of Pediatrics, Salt Lake City, Utah 84132, USA. aurelia.ehrig@hsc.utah.edu
D018249:Adenoma, Oxyphilic; D002292:Carcinoma, Renal Cell / Q000235:genetics; D002878:Chromosomes, Human, Pair 1; D041321:Chromosomes, Human, X; D006801:Humans; D007680:Kidney Neoplasms / Q000145:classification / Q000235:genetics*; D014178:Translocation, Genetic; D009396:Wilms Tumor / Q000235:genetics